Article
Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19*2 loss of function polymorphism.
Journal of the American College of Cardiology - 9 Nov 2010
Bonello Laurent, Armero Sébastien, Ait Mokhtar Omar, Mancini Julien, Aldebert Philippe, Saut Noémie, Bonello Nathalie, Barragan Paul, Arques Stéphane, Giacomoni Marie-Paule, Bonello-Burignat Caroline, Bartholomei Marie-Noelle, Dignat-George Françoise, Camoin-Jau Laurence, Paganelli Franck
Abstract excerpt
OBJECTIVES: We aimed to investigate the biological impact of a tailored clopidogrel loading dose (LD) according to platelet reactivity monitoring in carriers of the cytochrome (CYP) 2C19*2 loss-of-function polymorphism undergoing percutaneous coronary intervention for an acute coronary syndromes. BACKGROUND: CYP2C19*2 polymorphism is associated with reduced clopidogrel metabolism and a worse prognosis after...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
